Page last updated: 2024-08-16

zolpidem and carbostyril

zolpidem has been researched along with carbostyril in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gage, TW	1
Barton, CL; Hutson, PH	1

Other Studies

2 other study(ies) available for zolpidem and carbostyril

Article	Year
New drugs from 1991-1992. Texas dental journal, 1993, Volume: 110, Issue:7 Topics: 1-Naphthylamine; Anti-Bacterial Agents; Anti-Infective Agents; Anticholesteremic Agents; Antineoplastic Agents; Antiviral Agents; Azithromycin; Butanones; Cardiovascular Agents; Clarithromycin; Drug Approval; Drug Combinations; Drug Interactions; Enoxacin; Finasteride; Flumazenil; Fluoroquinolones; Humans; Ketorolac Tromethamine; Lactams; Nabumetone; Pyridines; Quinolones; Sertraline; Tolmetin; Tromethamine; United States; United States Food and Drug Administration; Zolpidem	1993
L-701,324, a glycine/NMDA receptor antagonist, blocks the increase of cortical dopamine metabolism by stress and DMCM. European journal of pharmacology, 1997, May-20, Volume: 326, Issue:2-3 Topics: Animals; Carbolines; Cerebral Cortex; Diazepam; Dopamine; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; GABA Agonists; Male; Pyridines; Pyrrolidinones; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Restraint, Physical; Stress, Physiological; Zolpidem	1997

Article

Year

New drugs from 1991-1992.

Texas dental journal, 1993, Volume: 110, Issue:7

Topics: 1-Naphthylamine; Anti-Bacterial Agents; Anti-Infective Agents; Anticholesteremic Agents; Antineoplastic Agents; Antiviral Agents; Azithromycin; Butanones; Cardiovascular Agents; Clarithromycin; Drug Approval; Drug Combinations; Drug Interactions; Enoxacin; Finasteride; Flumazenil; Fluoroquinolones; Humans; Ketorolac Tromethamine; Lactams; Nabumetone; Pyridines; Quinolones; Sertraline; Tolmetin; Tromethamine; United States; United States Food and Drug Administration; Zolpidem

1993

L-701,324, a glycine/NMDA receptor antagonist, blocks the increase of cortical dopamine metabolism by stress and DMCM.

European journal of pharmacology, 1997, May-20, Volume: 326, Issue:2-3

Topics: Animals; Carbolines; Cerebral Cortex; Diazepam; Dopamine; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; GABA Agonists; Male; Pyridines; Pyrrolidinones; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Restraint, Physical; Stress, Physiological; Zolpidem

1997